GPW 2026 PROGRAM

Psychedelics: Longevity, Consciousness & Human Potential

This panel brings together the biology of aging and healthspan with the lived experience of growing older and dying well, as speakers examine inflammation and the gut-brain axis as drivers of psychedelic response, alongside psilocybin's role in rites of passage into elder age and in building a genuine discipline of psychedelic end-of-life care.
A journalist's critical look at the longevity and healthspan claims circulating in the psychedelic space, separating what the evidence actually supports from the hype driving headlines and retreat marketing.
1 hour lunch break
This panel explores integration as the heart of psychedelic transformation. Speakers will examine how extraordinary states of consciousness reshape identity, belonging, and wholeness long after the experience itself has ended.
This panel explores what it takes to grow through psychedelics and what it takes to responsibly guide that growth, as speakers examine why high achievers turn to the medicine and what they find beneath their success, alongside the training, trauma-awareness, and harm-reduction practices required to hold that work safely for others.

This panel bridges indigenous and ancestral psychedelic traditions with modern clinical practice, as speakers draw on Shipibo lineage, structured therapy settings, and firsthand jungle experience to ask what Western psychedelic-assisted therapy still has to learn from the wisdom it borrowed from.
This panel explores gender, equity, and community as three sides of the same question: who psychedelic spaces are built for, who still gets left out, and what it takes to build community and support systems that make healing last well beyond the ceremony.
1 hour lunch break
This panel tracks how psychedelics are understood from the outside in, as speakers take on the myths and stigma shaping public opinion, question what AI can and can't capture about consciousness and the living world, and explore cultivation culture's own quieter history alongside the louder public conversation.

KEYNOTE - Betty Aldworth
A forward-looking keynote on where psychedelic medicine goes from here, looking past the current wave of research and legalization to what the field still needs to get right as it scales.
This panel examines the legal and economic realities shaping who can access psychedelic care, from regulatory frameworks and cost-effectiveness to the gaps still keeping people out of treatment.
1 hour lunch break
This panel ventures into the lesser-charted corners of the psychedelic landscape, as speakers explore emerging substances, novel practices, and alternative applications, from Amanita muscaria and extended-state DMT to iboga's role in addiction treatment and long-term recovery.
This panel examines the hidden dynamics of facilitation, from power and ethics to why personalized care matters more than rigid protocol.

Elephant Gate
A candid conversation on where AI fits into the psychedelic field, exploring what it can responsibly take on and where its limits should be.
1 hour lunch break
This panel confronts the tension at the center of building a psychedelic industry. Speakers will ask what it takes to scale a business without compromising the medicine's integrity, and whether conscious leadership can withstand the incentives capitalism imposes.
KEYNOTE: Christian Angermayer